Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1416)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expert Consensus and Clinical Pathway Recommendations for Transthyretin Amyloid Cardiomyopathy in Malaysia. (2026/07/22) ♡
- Sex based differences in clinical outcomes among heart failure patients with cardiac amyloidosis on sodium glucose Co-transporter-2 inhibitor therapy: A propensity score-matched analysis. (2026/07/21) ♡
- Bioepidemiology of cardiac amyloidosis. (2026/07/21) ♡
- Percutaneous coronary interventions improve phasic cardiac-coronary interaction in chronic coronary syndromes as assessed by wave intensity analysis. (2026/07/21) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. From access to action in ATTR cardiomyopathy: are we missing opportunities for therapy optimization? (2026/07/20) ♡
- Clinical outcomes, frailty and biomarker profiles in cardiac amyloidosis-related worsening heart failure: an exploratory analysis. (2026/07/20) ♡
- Efficacy and Safety of BCMA-Targeted Therapies in Relapsed or Refractory AL Amyloidosis: A Descriptive Pooled Analysis. (2026/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. In-hospital outcomes of sepsis hospitalizations among patients with cardiac amyloidosis: A 2022 National inpatient sample analysis. (2026/07/18) ♡
- Frailty status, clinical and functional outcomes in cardiac amyloidosis: a systematic review and meta-analysis. (2026/07/18) ♡
- Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study. (2026/07/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Val142Ile ATTR Cardiomyopathy: From Disease Progression to Clinical Stabilization With Vutrisiran. (2026/07/17) ♡
- Gene/Genome Editing in Cardiovascular Biology and Disease. (2026/07/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: When peripheral neuropathy meets hoarseness and cough: a diagnostic challenge and insights from a case of late-onset ATTRv. (2026/07/17) ♡
- Decision-curve analysis and the incremental value of cardiac MRI in transthyretin cardiac amyloidosis. (2026/07/16) ♡
- Real-world outcomes of tafamidis in transthyretin amyloid cardiomyopathy. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Imaging Advances in Light Chain Amyloidosis. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular Magnetic Resonance Elastography: Current Evidence, Challenges, and Future Perspectives. (2026/07/16) ♡
- A Progressive (99m)Tc-MDP Uptake in Transthyretin Cardiac Amyloidosis. (2026/07/15) ♡
- The Progressive Cardiac Uptake of (99m)Tc-MDP as a Clue to Transthyretin Amyloidosis. (2026/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Disease-Modifying Therapies for Hereditary Transthyretin Amyloidosis with Polyneuropathy: Current Status and Future Perspectives. (2026/07/15) ♡
- Shortness of Breath Due to a Large Spontaneous Left Atrial Intramural Hematoma. (2026/07/15) ♡
- A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis. (2026/07/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bilateral atrial appendage thrombosis in light chain cardiac amyloidosis: a case report. (2026/07/15) ♡
- Mechanistic Insights Into Metal Binding in the Aggregation Pathway of an Immunoglobulin Light Chain Protein. (2026/07/14) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Serum transthyretin as a staging biomarker in ATTR cardiomyopathy: promise, limitations, and the path forward. (2026/07/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Screening for Transthyretin Amyloidosis During Carpal Tunnel Release: An Opportunity for Early Diagnosis. (2026/07/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Low-Flow, Low-Gradient Aortic Stenosis in Transthyretin Cardiac Amyloidosis: Diagnostic and Therapeutic Challenges-A Case Report. (2026/07/13) ♡
- Home Dobutamine Infusion Combined with Opioid Therapy in Patients with Advanced Heart Failure. (2026/07/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Recurrent Pleural Effusion and Grade 3 Pyrophosphate Uptake in Cardiac Immunoglobulin Light Chain (AL) Amyloidosis: A Transthyretin Amyloidosis (ATTR) Phenocopy. (2026/07/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Coexistence of hereditary transthyretin amyloid cardiomyopathy and sarcomeric hypertrophic cardiomyopathy: a multimodality imaging and genetic case report. (2026/07/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Fibrosis in Cardiac Amyloidosis: How Much, How Relevant? (2026/07/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply: Fibrosis in Cardiac Amyloidosis: How Much, How Relevant? (2026/07/10) ♡
- Cardiovascular Mortality in Amyloidosis: Long-Term Trends, Disparities, and Projections in the United States. (2026/07/09) ♡
- Meta-Analysis of SGLT2 Inhibitors in Transthyretin Cardiac Amyloidosis: Insights by Disease-Modifying Therapy. (2026/07/09) ♡
- A Potential Approach to Bridge the Diagnostic Gap and Propose a Referral Pathway for Suspected ATTR-CA Based on Incidental Cardiac Uptake in (99m)Tc-MDP Bone Scans: A Pilot Descriptive Study. (2026/07/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Echocardiographic assessment of left atrioventricular coupling index: technical approaches and clinical implementation strategies. (2026/07/03) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Machine learning-based methods in diagnosing cardiac amyloidosis: a meta-analysis. (2026/07/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extracellular volume fraction by cardiac computed tomography (ECV(CT)): opportunities and challenges for clinical implementation. (2026/07/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Predictors of poor prognosis in a large cohort of patients with hereditary cardiac transthyretin amyloidosis. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Screening for transthyretin amyloid cardiomyopathy in patients with musculoskeletal symptoms: Red flags in the rheumatology/orthopedics practice setting. (2026/07/01) ♡
- Extracellular Volume Mapping by Cardiac MRI Predicts Sudden Cardiac Death in AL Amyloidosis: A South Asian Cohort Study. (2026/07/01) ♡
- [Epidemiology and burden on the National Health Service of cardiomyopathy associated with transthyretin amyloidosis based on administrative health data.]. (2026/07/01) ♡
- A No-Code, Guideline-Based Custom GPT Outperforms Cardiologists in Response Quality for Cardiac Amyloidosis. (2026/07/01) ♡
- Cardiac Remodelling After Transcatheter and Surgical Aortic Valve Replacement: A Tough Call. (2026/07/01) ♡
- Catheter ablation versus no ablation for atrial fibrillation in cardiac amyloidosis: a propensity-matched cohort study. (2026/06/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transthyretin Cardiac Amyloidosis in an Older Athlete. (2026/06/29) ♡
- The value of speckle tracking echocardiography in early identification of subclinical cardiac involvement in patients with multiple myeloma: a pilot retrospective study. (2026/06/26) ♡
- Prognostic Utility of Regional Longitudinal Strain in Patients With Immunoglobulin Light-Chain Cardiac Amyloidosis: A Report From the J-CASE Multicenter Survey. (2026/06/23) ♡
- Two Decades of Light-Chain Amyloidosis: Real-World Trends in Diagnosis, Treatment, and Survival. (2026/06/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Congo Red Unmasks the Culprit Behind Gastrointestinal Bleeding. (2026/06/19) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.